Coloplast strategy focuses on long-term growth, shares supported by stable sector peers

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-28, 10:00.

Coloplast (DK0060448595) continues to emphasize long-term growth in its core medical devices business. The company stands alongside sector peers such as Smith & Nephew and Zimmer Biomet, which also focus on chronic care and surgical solutions.

Long-term positioning in health care

Coloplast develops and sells products aimed at chronic care patients, particularly in ostomy care, continence care and wound care. The company targets stable, recurring demand from long-term conditions treated in hospitals and home-care settings. Its strategy focuses on incremental innovations and close collaboration with healthcare professionals.

The company operates in a global medical technology sector where steady demand is driven by aging populations, higher rates of chronic disease and expanding access to healthcare services. Peers such as Smith & Nephew and Zimmer Biomet have similar exposure to orthopedic and wound management products, providing investors with a recognizable comparison group in the broader healthcare equipment industry.

Focus on recurring revenue and margins

Coloplast’s business model is built around recurring revenue from consumable products such as ostomy bags and wound dressings, which are used continuously by patients over long periods. This type of product mix tends to support relatively stable cash flows and provides a basis for ongoing reinvestment in product development and geographic expansion.

In parallel, the company seeks to maintain margins through cost control, manufacturing efficiencies and careful pricing strategies. Healthcare payers, including national health systems and private insurers, remain sensitive to costs, so the company’s long-term strategy must balance innovation and reimbursement pressures in key markets.

The products behind the stock

Coloplast is well known for its ostomy care portfolio, including Ostomy bags and related accessories that help patients manage life after intestinal surgery. The company also markets continence care catheters and wound care products, which form part of a broader chronic care offering.

Where the stock trades today

The Coloplast shares (DK0060448595) trade on the Copenhagen exchange, with prices quoted in Danish kroner. At the last observable close, the shares were listed on Nasdaq Copenhagen in regular trading.

This text is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. All data are based on publicly available information believed to be reliable at the time of writing, but their accuracy cannot be guaranteed and may change without notice. Investors should conduct their own research or consult a professional advisor before making investment decisions.